Grünenthal Meds

1 follower


Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. T... Read more

Employees

51-200

Links

Org chart

Christoph Stolle
Chief Executive Officer

Christoph Stolle

Collapse
Rob May
Vp, Head Of Business Development And Partner Business
Chris Fuller
Regional Brands Director (emea)
Ian Povall
Head Of Commercial Operations Uk&i
Bhavika Patel
Senior Regulatory Affairs Associate